产品介绍
戊型病毒性肝炎是一种自愈性传染病,其传播方式、临床表现和预后均与甲型肝炎(甲肝)类似,孕妇患戊肝病死率高为本型肝炎的特点。
|
EV64
|
rAg
|
|
E.coli
|
包被/标记
|
酶免、发光、层析
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human IL21 Recombinant Antibody , PerCP|抗人IL21重组抗体,PerCP(靶标:人白细胞介素-21) |
138 |
| Anti-Human CD360/IL21R Recombinant Antibody, PerCP|抗人CD360/IL21R重组抗体,PerCP(靶标:人IL-21受体) |
181 |
| Anti-Mouse CD360/IL21R Recombinant Antibody , PerCP|抗小鼠CD360/IL21R重组抗体,PerCP(靶标:小鼠IL-21受体) |
372 |
| Anti-Human GP6 Recombinant Antibody , PerCP|抗人GP6重组抗体,PerCP(靶标:人糖蛋白VI) |
430 |
| Anti-Human CD248 Recombinant Antibody , PerCP|抗人CD248重组抗体,PerCP(靶标:人CD248(Endosialin)) |
155 |
| Anti-Human CD248 Recombinant Antibody, PerCP|抗人CD248重组抗体,PerCP(靶标:人CD248(Endosialin)) |
122 |
| Anti-Mouse CD248 Recombinant Antibody, PerCP|抗小鼠CD248重组抗体,PerCP(靶标:小鼠CD248(Endosialin)) |
405 |
| Anti-Mouse CD248 Recombinant Antibody, PerCP|抗小鼠CD248重组抗体,PerCP(靶标:小鼠CD248(Endosialin)) |
391 |
| Anti-Human CD209 Recombinant Antibody, PerCP|抗人CD209重组抗体,PerCP(靶标:人CD209(DC-SIGN)) |
235 |
| Anti-Human CD266/TNFRSF12A Recombinant Antibody , PerCP|抗人CD266/TNFRSF12A重组抗体,PerCP(靶标:人TWEAK受体(TNFRSF12A)) |
270 |
| Anti-Human CD354/TREM1 Recombinant Antibody, PerCP|抗人CD354/TREM1重组抗体,PerCP(靶标:人髓系细胞触发受体1) |
140 |
| Anti-Human IL23A Recombinant Antibody , PerCP|抗人IL23A重组抗体,PerCP(靶标:人IL-23 p19亚基) |
147 |
| Anti-Human IL23A Recombinant Antibody , PerCP|抗人IL23A重组抗体,PerCP(靶标:人IL-23 p19亚基) |
192 |
| Anti-Human IL1RAP Recombinant Antibody , PerCP|抗人IL1RAP重组抗体,PerCP(靶标:人IL-1受体辅助蛋白) |
397 |
| Anti-Human CD93/C1qR Recombinant Antibody, PerCP|抗人CD93/C1qR重组抗体,PerCP(靶标:人CD93(C1qR)) |
149 |
| Anti-Human CD93/C1qR Recombinant Antibody, PerCP|抗人CD93/C1qR重组抗体,PerCP(靶标:人CD93(C1qR)) |
208 |
| Anti-Human CD319/SLAMF7 Recombinant Antibody, PerCP|抗人CD319/SLAMF7重组抗体,PerCP(靶标:人SLAMF7(CD319)) |
419 |
| Anti-Human CD319/SLAMF7 Recombinant Antibody, PerCP|抗人CD319/SLAMF7重组抗体,PerCP(靶标:人SLAMF7(CD319)) |
240 |
| Anti-Human DLL4 Recombinant Antibody , PerCP|抗人DLL4重组抗体,PerCP(靶标:人Delta样配体4) |
197 |
| Anti-Human DLL4 Recombinant Antibody , PerCP|抗人DLL4重组抗体,PerCP(靶标:人Delta样配体4) |
144 |